Journey Medical Corp (DERM) — Cash Flow-to-Debt Ratio
Journey Medical Corp (DERM) has a Cash Flow-to-Debt Ratio of -0.10x as of December 2025, meaning its operating cash flow of $-6.36 Million could theoretically repay 0% of its total liabilities ($62.74 Million) in one year. See DERM free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Journey Medical Corp Cash Flow-to-Debt Ratio (2014–2025)
Historical debt coverage capacity for Journey Medical Corp across 12 annual periods. Also explore Journey Medical Corp annual equity growth to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Journey Medical Corp (2014–2025)
Year-by-year debt coverage analysis for Journey Medical Corp. For market capitalisation and broader financial context, see DERM market cap overview.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.20x | $-12.44 Million | $62.74 Million | ▼ -30.7% |
| 2024 | -0.15x | $-9.13 Million | $60.17 Million | ▼ -263.5% |
| 2023 | 0.09x | $5.24 Million | $56.50 Million | ▲ +160.4% |
| 2022 | -0.15x | $-13.53 Million | $88.18 Million | ▼ -288.8% |
| 2021 | -0.04x | $-2.18 Million | $55.24 Million | ▼ -132.0% |
| 2020 | 0.12x | $5.13 Million | $41.61 Million | ▼ -57.5% |
| 2019 | 0.29x | $9.02 Million | $31.11 Million | ▲ +148.1% |
| 2018 | -0.60x | $-213.10 Million | $353.36 Million | ▼ -138.5% |
| 2017 | -0.25x | $-103.96 Million | $411.14 Million | ▲ +77.7% |
| 2016 | -1.14x | $-74.11 Million | $65.23 Million | ▲ +14.5% |
| 2015 | -1.33x | $-48.44 Million | $36.46 Million | ▼ -4.3% |
| 2014 | -1.27x | $-31.40 Million | $24.64 Million | — |